original ) (raw )Maternal serum screening for Down's syndrome in the first trimester of pregnancy
Ettore Cariati
BJOG: An International Journal of Obstetrics and Gynaecology, 1995
View PDFchevron_right
Maternal serum screening for Down's syndrome in early pregnancy
James Densem
BMJ, 1988
View PDFchevron_right
Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha- fetoprotein and unconjugated oestriol
Bernadette Mermillod
Human Reproduction, 1998
View PDFchevron_right
Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome
Nan Okun
Prenatal Diagnosis, 2010
View PDFchevron_right
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy
James Densem
BJOG: An International Journal of Obstetrics and Gynaecology, 1996
View PDFchevron_right
Reproducibility of risk figures in 2nd-trimester maternal serum screening for Down syndrome: comparison of 2 laboratories
Peter Benn
Clinical chemistry, 2006
View PDFchevron_right
The effect of a 'vanishing twin' on biochemical and ultrasound first trimester screening markers for Down's syndrome in pregnancies conceived by assisted reproductive technology
A. Tabor
Human Reproduction, 2008
View PDFchevron_right
Maternal serum markers in screening for Down syndrome
Ann Tabor
Clinical Genetics, 2008
View PDFchevron_right
A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol
Gail Prins
American Journal of Obstetrics and Gynecology, 1993
View PDFchevron_right
Second Trimester Antenatal Screening for Down’s Syndrome
Guido Vranken
View PDFchevron_right
The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome
John Owen
American Journal of Obstetrics and Gynecology, 1994
View PDFchevron_right
Down syndrome screening marker levels in women with a previous aneuploidy pregnancy
Kevin Spencer
Prenatal Diagnosis, 2005
View PDFchevron_right
eta-analysis of first trimester Down syndrome screening tudies: free -human chorionic gonadotropin significantly utperforms intact human chorionic gonadotropin in a ultimarker protocol
Robert Galen
2007
View PDFchevron_right
Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women
Karin Sundberg
Ultrasound in Obstetrics and Gynecology, 2005
View PDFchevron_right
Repeat maternal serum testing in multiple marker down's syndrome screening programmes
James Densem
Prenatal Diagnosis, 1994
View PDFchevron_right
Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing
Peter Benn
Clinica Chimica Acta, 2002
View PDFchevron_right
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome
James Densem
BJOG: An International Journal of Obstetrics and Gynaecology, 1988
View PDFchevron_right
Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight
James Densem
BJOG: An International Journal of Obstetrics and Gynaecology, 1992
View PDFchevron_right
The use of free beta-hCG in antenatal screening for Down's syndrome
James Densem
BJOG: An International Journal of Obstetrics and Gynaecology, 1993
View PDFchevron_right
Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study
Isabelle Czerkiewicz
American Journal of Obstetrics and Gynecology, 2013
View PDFchevron_right
α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome
John Owen
American Journal of Obstetrics and Gynecology, 1997
View PDFchevron_right
Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome
Hilary Watt
Prenatal Diagnosis, 1994
View PDFchevron_right
First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free β-hCG and pregnancy-associated plasma protein-A assays
Kevin Spencer
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2005
View PDFchevron_right
Introduction of first trimester combined test increases uptake of Down's syndrome screening
Tariq Nawaz
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
View PDFchevron_right
A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome
Françoise Muller
Prenatal Diagnosis, 1990
View PDFchevron_right
A new simple and rapid dual assay for AFP and free β hCG in screening for Down syndrome
Ulf-Håkan Stenman
Clinical Genetics, 2008
View PDFchevron_right
Antenatal screening for Down's syndrome in assisted reproductive pregnancies
Eli Dreazen
Human Reproduction Update, 1999
View PDFchevron_right
Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies
Shohreh Shahabi
American Journal of Obstetrics and Gynecology, 2000
View PDFchevron_right
Prenatal diagnosis of Down syndrome in dizygotic twin pregnancy
Dariusz Borowski
Polish Gynaecology, 2013
View PDFchevron_right
Comparison of First Trimester Screening for Down’s Syndrome Using Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A Levels between Spontaneous and IVF Pregnancies at 12 Weeks of Gestation
Robabeh Taheripanah
International Journal of Fertility & Sterility, 2019
View PDFchevron_right
Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndrome
James Densem
BJOG: An International Journal of Obstetrics and Gynaecology, 1989
View PDFchevron_right
Meta-analysis of first trimester Down syndrome screening studies: free β-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol
Robert Galen
American Journal of Obstetrics and Gynecology, 2007
View PDFchevron_right
Down’s Syndrome Screening in the First Trimester with Additional Serum Markers: Indian Parameters
sujatha jagadeesh
The Journal of Obstetrics and Gynecology of India
View PDFchevron_right
Elevated second trimester dimeric inhibin a levels identify down syndrome pregnancies
John Owen
American Journal of Obstetrics and Gynecology, 1997
View PDFchevron_right
Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay
Kevin Spencer
Prenatal Diagnosis, 2003
View PDFchevron_right